Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04943575 · ClinicalTrials.gov registry record · NA
Study to Evaluate the Efficacy of EZC Pak in Adults With Upper Respiratory Infection (URI)
A NA study of Common Cold, sponsored by PPC Pharmaceuticals.
- Completed
- Registry status
- NA
- Development phase
- 360
- Enrollment target
- 1
- Study location
NCT04943575 is a NA study of Common Cold that has completed, run by PPC Pharmaceuticals. The registered enrollment target is 360 participants, roughly in line with the 362-participant average among 5 other Common Cold trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT04943575, a NA study of Common Cold, has completed, sponsored by PPC Pharmaceuticals.
- COMPLETED
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized-controlled interventional clinical trial to evaluate the effectiveness of EZC Pak \& EZC Pak+D for the treatment of the common cold and/or a URI.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT EZC Pak
- DIETARY_SUPPLEMENT EZC Pak +D
Study Locations (1)
California
- Citruslabs - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2022-01-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04943575
The ClinicalTrials.gov registry entry for NCT04943575 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 362-participant average among 5 other Common Cold trials with a reported enrollment target. The listed sponsor is PPC Pharmaceuticals, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Common Cold appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.
NCT04943575 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT04943575 about?
NCT04943575 is a clinical study titled "Study to Evaluate the Efficacy of EZC Pak in Adults With Upper Respiratory Infection (URI)". A randomized-controlled interventional clinical trial to evaluate the effectiveness of EZC Pak \& EZC Pak+D for the treatment of the common cold and/or a URI.
What is the current status of trial NCT04943575?
This trial is currently completed. It is a NA study. The enrollment target is 360 participants. The study started on 2021-06-01. Estimated completion is 2022-01-30.
What conditions does trial NCT04943575 study?
This clinical trial studies the following conditions: Common Cold.
What interventions are being tested in trial NCT04943575?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), EZC Pak (DIETARY_SUPPLEMENT), EZC Pak +D (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04943575?
This trial is sponsored by PPC Pharmaceuticals, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04943575 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Common Cold
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Throat Spray on the Incidence and Duration of Sickness
ACTIVE NOT RECRUITING · NA
-
A Clinical Evidence Study Evaluating Quality of Life Parameters Following Treatment With Robitussin
COMPLETED · Phase 4
-
Efficacy Trial of 3804-250A in the Prevention of Cold Illnesses
COMPLETED · Phase 2
-
Echinacea Versus Placebo Effect in Common Cold (Physician Echinacea Placebo)
COMPLETED · Phase 3
-
Audio Data Collection for Identification and Classification of Coughing
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.